Genetically attenuated parasites
Showing 1 - 25 of 1,585
Malaria,Falciparum Trial in Leiden (biological, drug, other)
Not yet recruiting
- Malaria,Falciparum
- GA2
- +4 more
-
Leiden, NetherlandsLeiden University Medical Center
Jul 18, 2022
Malaria,Falciparum, Plasmodium Falciparum, Plasmodium Berghei Trial in Nijmegen, Rotterdam (Pb(PfCS@UIS4)-infected mosquitoes,
Completed
- Malaria,Falciparum
- +3 more
- Pb(PfCS@UIS4)-infected mosquitoes
- Challenge infection P. falciparum
-
Nijmegen, Gelderland, Netherlands
- +1 more
Feb 23, 2022
Plasmodium Falciparum Infection Trial in Seattle (Genetically-attenuated p52-/p36-/sap1- Plasmodium falciparum parasite (GAP3KO)
Completed
- Plasmodium Falciparum Infection
- Genetically-attenuated p52-/p36-/sap1- Plasmodium falciparum parasite (GAP3KO) strain
- Malaria challenge
-
Seattle, WashingtonKaiser Permanente Washington Health Research Institute - Vaccine
Sep 19, 2019
Malaria Trial in Silver Spring (p52-/p36- GAP Vaccine, p52-p36- GAP Vaccine)
Terminated
- Malaria
- p52-/p36- GAP Vaccine
- p52-p36- GAP Vaccine
-
Silver Spring, MarylandWalter Reed Army Institute of Research
Oct 4, 2019
Malaria Trial in Leiden, Nijmegen (PfSPZ-GA1 Vaccine, PfSPZ Vaccine, Normal Saline)
Completed
- Malaria
- PfSPZ-GA1 Vaccine
- +3 more
-
Leiden, Netherlands
- +1 more
Mar 4, 2019
Metastatic Pancreatic Cancer Trial in Montreal (Salmonella-IL2, FOLFIRINOX Alone (Historical Controls), Gemcitabine/Abraxane
Recruiting
- Metastatic Pancreatic Cancer
- Salmonella-IL2
- +2 more
-
Montreal, Quebec, CanadaSegal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial
May 3, 2022
GSK's Phase IIb Malaria Vaccine Trial Entitled "Efficacy, Safety
Active, not recruiting
- Malaria
-
Kumasi, Ghana
- +1 more
Jun 23, 2022
Advanced Solid Tumor Trial in Switzerland, United Kingdom (Pembrolizumab+T3P-Y058-739, T3P-Y058-739 (IV), T3P-Y058-739 (IT))
Recruiting
- Advanced Solid Tumor
- Pembrolizumab+T3P-Y058-739
- +2 more
-
Lausanne, Switzerland
- +4 more
Jun 22, 2022
Gastroenteritis Trial in China (GSK's liquid oral live attenuated HRV, PCV-free liquid formulation of GSK's oral live attenuated
Recruiting
- Gastroenteritis
- GSK's liquid oral live attenuated HRV
- PCV-free liquid formulation of GSK's oral live attenuated HRV
-
Chengdu, Sichuan, China
- +7 more
Sep 7, 2023
Liver Cirrhosis Trial in Sohag (stool analysis)
Not yet recruiting
- Liver Cirrhosis
- stool analysis
-
Sohag, EgyptSohag university hospital
May 3, 2023
Malaria Trial in Lambaréné (PfSPZ Vaccine, Normal Saline)
Completed
- Malaria
- PfSPZ Vaccine
- Normal Saline
-
Lambaréné, Moyen-Ogooué, GabonCentre de Recherches Médicales de Lambaréné (CERMEL)
Oct 6, 2021
Varicella Zoster Virus Infection Trial (MG1111)
Not yet recruiting
- Varicella Zoster Virus Infection
- MG1111
- (no location specified)
Dec 16, 2022
Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-Lumefantrine-Amodiaquine (ALAQ)
- +2 more
- (no location specified)
Jul 20, 2023
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023
Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)
Recruiting
- Adenovirus Infection
- +6 more
- Virus-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jan 6, 2023
Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Carboplatin, Pemetrexed, Paclitaxel)
Recruiting
- Lung Cancer
- +2 more
- Carboplatin
- +9 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Mar 24, 2023
Varicella Trial in Xuzhou (Investigational live attenuated varicella vaccine (lot 1), Investigational live attenuated varicella
Not yet recruiting
- Varicella
- Investigational live attenuated varicella vaccine (lot 1)
- +2 more
-
Xuzhou, Jiangsu, ChinaXinyi Center for Disease Control and Prevention
Apr 20, 2023
Malaria,Falciparum, Malaria in Pregnancy, Malaria in Childbirth Trial in Kinshasa, Eldoret (Malaria High-Sensitivity Rapid
Not yet recruiting
- Malaria,Falciparum
- +8 more
- Malaria High-Sensitivity Rapid Diagnostic Test (HS-RDT)
- Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
-
Kinshasa, Congo, The Democratic Republic of the
- +1 more
Feb 24, 2023
NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting
Not yet recruiting
- Non-small Cell Lung Cancer
- +5 more
- Autologous, engineered T Cells targeting TP53 R175H
-
Duarte, CaliforniaCity of Hope
May 17, 2023
Varicella Trial in Xuzhou (Investigational live attenuated varicella vaccine, Placebo of live attenuated varicella vaccine)
Recruiting
- Varicella
- Investigational live attenuated varicella vaccine
- Placebo of live attenuated varicella vaccine
-
Xuzhou, Jiangsu, ChinaPei County Center for Disease Control and Prevention
Jan 18, 2023
Bacterial Growth, Novel Influenza A (H1N1) Trial in Jilin (A novel electrolyzed water spray reduces numbers of bacteria E-coli
Recruiting
- Bacterial Growth
- Novel Influenza A (H1N1)
- A novel electrolyzed water spray reduces numbers of bacteria E-coli and an attenuated human flu virus on human hands
-
Jilin, Changchun, ChinaChangchun Jiahe Surgery Hospital
Apr 1, 2023
Malaria Trial in Bagamoyo (SumayaVac-1(SUM-101), Verorab, CHMI)
Not yet recruiting
- Malaria
- SumayaVac-1(SUM-101)
- +2 more
-
Bagamoyo, TanzaniaIfakara Health Institute
Dec 1, 2022
Severe Malaria Trial in Worldwide (KAE609, IV Artesunate, Coartem)
Recruiting
- Severe Malaria
- KAE609
- +2 more
-
Kinsasha, Democratic Republic Of Congo, Congo
- +6 more
Sep 23, 2022
ß-thalassemia Trial in Shanghai (BD211)
Not yet recruiting
- β-thalassemia
- BD211
-
Shanghai, ChinaShanghai Ruijin Hospital
Mar 16, 2023
Respiratory Syncytial Virus Infection Trial in Carolina, Guayama, San Juan (RSVt Vaccine, Control Group)
Recruiting
- Respiratory Syncytial Virus Infection
- RSVt Vaccine
- Control Group
-
Carolina, Puerto Rico
- +2 more
Feb 2, 2023